Frontotemporal dementia patients with extrapyramidal symptoms have brainstem atrophy and reduced metabolism in certain areas of the brain significantly more often than patients without extrapyramidal ...

Several neuropsychiatric diseases have a characteristic late onset pattern and therefore predominantly affect the elderly. Moreover, aging may be a risk factor for the development of neurological and ...

Frontotemporal dementia patients with extrapyramidal symptoms have brainstem atrophy and reduced metabolism in certain areas of the brain significantly more often than patients without extrapyramidal ...

Credit: Getty Images. Extrapyramidal symptoms that developed in patients with schizophrenia after initiation of treatment with atypical antipsychotic agents were associated with increased healthcare ...

Depression with anxiety disorder started in summer of 2004. From 28/7/2004 to 22/11/2004 (4 months) the patient was taking Citalopram 20 mg per day and Alprazolam 0.5 mg three times per day. On ...

AS the so-called "tranquilizing drugs" continue to increase in use and misuse, the physician will become more aware of the alarming side reactions that may be inherent in their pharmacologic formulas.

Prevention of relapse is a major goal of maintenance treatment in patients with psychotic disorders. We performed a long-term comparison of a newer, atypical antipsychotic drug, risperidone, and an ...

The approval of Osmolex ER was based on bioavailability studies comparing Osmolex ER to immediate-release amantadine. Osmotica announced that the Food and Drug Administration (FDA) has approved ...